IGHE and food allergy: Current Canadian, patient-centred, clinical practice guidelines recommend OIT for patients with IgE-mediated food allergy wishing to receive it, provided that there are no contraindications to therapy and that patients and caregivers clearly understand the benefits and risks of therapy.